Muscarinic acetylcholine receptor M3

From WikiMD's WELLNESSPEDIA

Muscarinic acetylcholine receptor M3 (also known as M3 receptor or mAChR M3) is a type of muscarinic acetylcholine receptor that plays a crucial role in the human body. It is encoded by the human gene CHRM3.

Function[edit]

The M3 receptor is a G protein-coupled receptor that is predominantly found in the smooth muscle, glandular tissue, and the central nervous system. It is involved in various physiological processes, including smooth muscle contraction, glandular secretion, and modulation of neurotransmitter release.

Structure[edit]

The M3 receptor is a member of the muscarinic acetylcholine receptor family, which consists of five different subtypes (M1-M5). Like all G protein-coupled receptors, the M3 receptor has seven transmembrane domains, an extracellular N-terminus, and an intracellular C-terminus.

Clinical significance[edit]

Alterations in the function or expression of the M3 receptor have been implicated in various diseases, including asthma, chronic obstructive pulmonary disease (COPD), Sjögren's syndrome, and overactive bladder syndrome. Therefore, the M3 receptor is considered a potential therapeutic target for these conditions.

Pharmacology[edit]

Several drugs target the M3 receptor to treat various conditions. For example, antimuscarinic drugs like tiotropium and ipratropium are used to treat respiratory conditions such as asthma and COPD, while mirabegron is used to treat overactive bladder syndrome.

See also[edit]

References[edit]







Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.